These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 18546007
1. The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity. Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Pietrzyk JJ. Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1467-75. PubMed ID: 18546007 [Abstract] [Full Text] [Related]
2. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity. Pieh C, Agostini H, Buschbeck C, Krüger M, Schulte-Mönting J, Zirrgiebel U, Drevs J, Lagrèze WA. Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080 [Abstract] [Full Text] [Related]
3. Polymorphisms of Vascular Endothelial Growth Factor and Retinopathy of Prematurity. Ali AA, Hussien NF, Samy RM, Husseiny KA. J Pediatr Ophthalmol Strabismus; 2015 May; 52(4):245-53. PubMed ID: 25992764 [Abstract] [Full Text] [Related]
4. Effect of laser photocoagulation on plasma levels of VEGF-A, VEGFR-2, and Tie2 in infants with retinopathy of prematurity. Yalin Imamoglu E, Gunay M, Gursoy T, Imamoglu S, Balci Ekmekci O, Celik G, Karatekin G, Ovali F. J AAPOS; 2014 Oct; 18(5):466-70. PubMed ID: 25266828 [Abstract] [Full Text] [Related]
5. An Updated and Comprehensive Meta-Analysis of Association between VEGA -634G > C, -460T > C, +405G > C and +936C > T Polymorphisms and Retinopathy of Prematurity Risk. Gohari M, Bahrami R, Dastgheib SA, Lookzadeh MH, Noorishadkam M, Mirjalili SR, Zare-Shehneh M, Neamatzadeh H. Fetal Pediatr Pathol; 2021 Jun; 40(3):233-249. PubMed ID: 31846376 [Abstract] [Full Text] [Related]
6. Associations of VEGF/VEGF-receptor and HGF/c-Met promoter polymorphisms with progression/regression of retinopathy of prematurity. Kaya M, Çokakli M, Berk AT, Yaman A, Yesilirmak D, Kumral A, Atabey N. Curr Eye Res; 2013 Jan; 38(1):137-42. PubMed ID: 23094709 [Abstract] [Full Text] [Related]
7. Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity. Wu WC, Lien R, Liao PJ, Wang NK, Chen YP, Chao AN, Chen KJ, Chen TL, Hwang YS, Lai CC. JAMA Ophthalmol; 2015 Apr; 133(4):391-7. PubMed ID: 25569026 [Abstract] [Full Text] [Related]
8. The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study. Kandasamy Y, Hartley L, Rudd D, Smith R. J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2202-2208. PubMed ID: 28573924 [Abstract] [Full Text] [Related]
9. Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity. Budd SJ, Thompson H, Hartnett ME. Arch Ophthalmol; 2010 Aug; 128(8):1014-21. PubMed ID: 20697002 [Abstract] [Full Text] [Related]
11. Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity. Hellgren G, Löfqvist C, Hård AL, Hansen-Pupp I, Gram M, Ley D, Smith LE, Hellström A. Pediatr Res; 2016 Jan; 79(1-1):70-5. PubMed ID: 26372519 [Abstract] [Full Text] [Related]
16. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Sato T, Kusaka S, Shimojo H, Fujikado T. Ophthalmology; 2009 Sep; 116(9):1599-603. PubMed ID: 19371954 [Abstract] [Full Text] [Related]
20. Circulating stem cell populations in preterm infants: implications for the development of retinopathy of prematurity. Machalinska A, Modrzejewska M, Kotowski M, Dziedziejko V, Kucia M, Kawa M, Safranow K, Baskiewicz-Masiuk M, Modrzejewska A, Karczewicz D, Rudnicki J, Machalinski B. Arch Ophthalmol; 2010 Oct; 128(10):1311-9. PubMed ID: 20938001 [Abstract] [Full Text] [Related] Page: [Next] [New Search]